DA32 Life Science Tech Acquisition Corp. financial data

Industry
Blank Checks
Location
345 Park Avenue South, 12 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 126 %
Debt-to-equity -140 %
Return On Equity -37.6 %
Return On Assets 0.85 %

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 161M USD -42.2%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 1.43M USD +33.9%
Operating Income (Loss) -1.84M USD -23.5%
Nonoperating Income (Expense) 1.57M USD +5120%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.15M USD
Income Tax Expense (Benefit) 329K USD
Net Income (Loss) Attributable to Parent 1.73M USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.1M USD +568%
Assets, Current 491K USD -77.2%
Assets 205M USD +1.37%
Accounts Payable, Current 0 USD -100%
Accrued Liabilities, Current 432K USD +91.5%
Liabilities, Current 1.35M USD +341%
Liabilities 6.95M USD +17.7%
Retained Earnings (Accumulated Deficit) -5.11M USD -38.2%
Stockholders' Equity Attributable to Parent -5.11M USD -38.2%
Liabilities and Equity 205M USD +1.37%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -395K USD -52.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 304K USD -81.1%
Deferred Tax Assets, Valuation Allowance 303K USD +152%
Cash and Cash Equivalents, Period Increase (Decrease) -260K USD
Deferred Tax Assets, Gross 423K USD +252%
Deferred Tax Assets, Operating Loss Carryforwards 0 USD -100%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 0 USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%